Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer

Information

Show

Journal of Clinical Oncology (JCO) Podcast

Published

October 16, 2024

Type

audio

Language

EN

Author

American Society of Clinical Oncology (ASCO)

Categories

healthfitnessmedicine